Today: 15 May 2026
Browse Category

NYSE:PTEN 3 April 2026

Oil Price Shock Deepens as Dated Brent Hits 2008 High and Iran War Chokes Hormuz

Oil Price Shock Deepens as Dated Brent Hits 2008 High and Iran War Chokes Hormuz

Dated Brent crude jumped to $141.37 a barrel Thursday, its highest since 2008, as the Strait of Hormuz remains blocked with no agreement to restore shipping. U.S. gasoline prices are projected to reach $4.25–$4.45 per gallon next week and could top $5 if the disruption continues. Pakistan raised fuel prices sharply, and Europe is considering rationing. WTI closed above Brent for the first time since May 2022.
3 April 2026
·

Stock Market Today

  • American Rare Earths Shows Strong Cash Position to Support Growth Plans
    May 15, 2026, 5:30 PM EDT. American Rare Earths (ASX:ARR) holds AU$26 million in cash with zero debt as of December 2025, providing a 2.3-year cash runway based on its AU$12 million annual cash burn. Despite a 23% increase in cash burn over the past year, the company's strong cash position gives it a prudent runway to support its early-stage growth without immediate funding concerns. With a market capitalization of AU$236 million, American Rare Earths appears well-positioned to raise further capital if needed to continue its growth trajectory.

Latest articles

Tonix Pharmaceuticals Stock Jumps as Lyme Disease Antibody Data Put 2027 Trial in Focus

Tonix Pharmaceuticals Stock Jumps as Lyme Disease Antibody Data Put 2027 Trial in Focus

15 May 2026
Tonix Pharmaceuticals filed new Phase 1 modeling data showing its experimental Lyme disease antibody, TNX-4800, could maintain serum levels above a proposed protective threshold for six months with a two-dose regimen. Shares rose $1.65 to $15.74 Friday. The company plans a Phase 2 trial in 2027, pending FDA agreement. No Lyme vaccine is currently available in the U.S.
AXT Stock’s AI Rally Hits Governance Snag as Annual Meeting Is Pushed to June

AXT Stock’s AI Rally Hits Governance Snag as Annual Meeting Is Pushed to June

15 May 2026
AXT adjourned its 2026 annual meeting after failing to reach a quorum, rescheduling for June 4. The company seeks shareholder approval to raise authorized common shares to 120 million from 70 million. Shares closed at $123.78, up 7.65%, after a volatile session. China’s export controls on indium phosphide remain a key risk for AXT’s business.
Hyperscale Data Climbs on $5 Million Tender Offer; Spotlight Turns to 10-Q

Hyperscale Data Climbs on $5 Million Tender Offer; Spotlight Turns to 10-Q

15 May 2026
Hyperscale Data plans a tender offer to buy up to $5 million of Class A shares at $0.21 each, above the last GPUS trade at $0.146. The company reported a preliminary first-quarter net loss of about $30 million on revenue of $44 million and filed a late notice for its Form 10-Q. The offer is pending board and regulatory approval.
Go toTop